These results point towards the possibility that Glt1 mRNA localization and translation are altered in astrocytic processes, however addressing whether the loss of the process-specific Glt1 mRNA isoform (Glt1a) [90] contributes to FXS would lead to more conclusive results. The gene discussed is SLC1A2; the disease is fragile X syndrome.